Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Implantable prosthesis – Bone
Reexamination Certificate
2008-04-28
2011-11-22
Willse, David H (Department: 3774)
Prosthesis (i.e., artificial body members), parts thereof, or ai
Implantable prosthesis
Bone
C623S020140, C623S023580, C623S908000
Reexamination Certificate
active
08062364
ABSTRACT:
A method for treating arthritis of a joint includes identifying a bone lesion in a bone adjacent to the joint; and implanting in the bone a reinforcing member in or adjacent to the bone lesion. A kit for conducting the method includes: (a) at least one reinforcing member having a proximal face adapted to face the joint, a distal face adapted to face away from the joint, and a wedge-shaped edge adapted to pierce bone, wherein the at least one reinforcing member is planar and sterile; and (b) a container adapted to maintain the at least one reinforcing member sterile. Another kit includes: (a) a sterile fluid; (b) a syringe for injecting the fluid into a bone; (c) a curing agent adapted to cure the fluid to polymerize and/or cross-link; and (d) a container adapted to maintain the sterility of contents of the container.
REFERENCES:
patent: 5273964 (1993-12-01), Lemons
patent: 5556429 (1996-09-01), Felt
patent: 5755809 (1998-05-01), Cohen et al.
patent: 5902825 (1999-05-01), Jia
patent: 6280474 (2001-08-01), Cassidy et al.
patent: 6395007 (2002-05-01), Bhatnagar et al.
patent: 6527810 (2003-03-01), Johnson et al.
patent: 6564083 (2003-05-01), Stevens
patent: 6607561 (2003-08-01), Brannon
patent: 6711432 (2004-03-01), Krause et al.
patent: 6767369 (2004-07-01), Boyer, II et al.
patent: 6818018 (2004-11-01), Sawhney
patent: 7166570 (2007-01-01), Hunter et al.
patent: 7425549 (2008-09-01), Little et al.
patent: 7442195 (2008-10-01), Behrens
patent: 2003/0055316 (2003-03-01), Brannon
patent: 2003/0055431 (2003-03-01), Brannon
patent: 2003/0135214 (2003-07-01), Fetto et al.
patent: 2005/0101673 (2005-05-01), Norden et al.
patent: 2005/0119219 (2005-06-01), Bellini et al.
patent: 2005/0251266 (2005-11-01), Maspero et al.
patent: 2006/0057184 (2006-03-01), Nycz et al.
patent: 2006/0172934 (2006-08-01), Nycz et al.
patent: 2007/0010440 (2007-01-01), Schense et al.
patent: 2007/0123894 (2007-05-01), Claypool et al.
patent: 2007/0259018 (2007-11-01), McKay
patent: 2007/0275028 (2007-11-01), Barry et al.
patent: 2007/0287988 (2007-12-01), Trebing et al.
patent: 2008/0031915 (2008-02-01), Becerra Ratia et al.
patent: 2008/0113008 (2008-05-01), Roche
patent: 2008/0294085 (2008-11-01), Stamps et al.
patent: 2008/0294269 (2008-11-01), Fell
patent: 2009/0081169 (2009-03-01), Egrise et al.
patent: 2009/0123378 (2009-05-01), Wong et al.
patent: 2010/0145451 (2010-06-01), Dee
patent: 2161929 (2001-01-01), None
patent: 2004080384 (2004-09-01), None
Arnoldi et al., “Intraosseous Phlebography, Intraosseous Pressure Measurements and 99mTC-Polyphosphate Scintigraphy in Patients with Various Painful Conditions in the Hip and Knee”, Acta Orthop Scand. 1980;51:19-28.
Bollet, “Edema of the bone marrow can cause pain in osteoarthritis and other diseases of bone and joints.” Ann Intern Med. Apr. 3, 2001;134(7):591-3.
Felson et al., “The association of bone marrow lesions with pain in knee osteoarthritis.” Ann Intern Med. Apr. 3, 2001:134(7):541-9.
Felson et al., “Bone marrow edema and its relation to progression of knee osteoarthritis.” Ann Intern Med. Sep. 2, 2003;139(5 Pt 1):330-6.
McAlindon et al., “Magnetic resonance imaging in osteoarthritis of the knee: correlation with radiographic and scintigraphic findings.” Ann Rheum Dis. 1991;50:14-9.
Zanetti et al., “Bone Marrow Edema Pattern in Osteoarthritic Knees: Correlation between MR Imaging and Histologic Findings.” Radiology. 2000;215:835-840.
Altman, et al.; “Development of Criteria for the Classification and Reporting of Osteoarthritis, Classification of Osteoarthritis in the Knee: Classification of Osteoarthritis of the Knee”; Arthritis & Rheumatism, Aug. 1986, 29(8): 1039-1049.
Baranyay, et al.; “Association of Bone Marrow Lesions with Knee Structures and Risk Factors for Bone Marrow Lesions in the Knees of Clinically Healthy, Community-Based Adults”; Seminar in Arthritis & Rheumatism, Oct. 2007: 112-118.
Bingham, et al.; “Risedronate Decreases Biochemical Markers of Cartilage Degradation but Does Not Decrease Symptoms or Slow Radiographic Progression in Patients with Medial Compartment Osteoarthritis of the Knee: Results of the Two-Year Multinational Knee Osteoarthritis Structural Arthritis Study”; Arthritis & Rheumatism, Nov. 2006, 54(11): 3494-3507.
Buckland-Wright, et al.; “A 2 Yr Longitudinal Radiographic Study Examining the Effect of a Bisphosphonate (Risedronate) Upon Subchondral Bone Loss in Osteoarthritic Knee Patients”; Rheumatology 2006, 46: 257-264.
Carbone, et al.; “The Relationship of Antiresorptive Drug Use to Structural Findings and Symptoms of Knee Osteoarthritis”; Arthritis & Rheumatism, Nov. 2004, 50(11): 3516-3525.
Cicuttini, et al.; “Association of Cartilage Defects with Loss of Knee Cartilage in Healthy, Middle-Aged Adults: A Prospective Study”; Arthritis & Rheumatism, Jul. 2005, 52(7): 2033-2039.
Cicuttini, et al.; “Comparison of Tibial Cartilage vol. And Radiologic Grade of the Tibiofemoral Joint”; Arthritis & Rheumatism, Mar. 2003, 48(3): 682-688.
Clegg, et al.; “Glucosamine, Chondroitin Sulfate, and the Two in Combination for Painful Knee Osteoarthritis”; The New England Journal of Medicine, Feb. 2006, 354(8): 795-808.
Felson, et al.; “Correlation of the Development of Knee Pain With Enlarging Bone Marrow Lesions on Magnetic Resonance Imaging”; Arthritis & Rheumatism, Sep. 2007, 56(9): 2986-2992.
Felson, et al.; “An Update on the Epidemiology of Knee and Hip Osteoarthritis with a View to Prevention”; Arthritis & Rheumatism, Aug. 1998, 41(8): 1343-1355.
Felson, et al.; “Obesity and Knee Osteoarthritis, the Framingham Study”; Annals of Internal Medicine, Jul. 1988, 109: 18-24.
Felson, et al.; “Osteoarthritis: Is it a Disease of Cartilage or of Bone?”; Arthritis & Rheumatism, Feb. 2004, 50 (2): 341-344.
Felson, et al.; “The Prevalence of Knee Osteoarthritis in the Elderly, the Framingham Osteoarthritis Study”; Arthritis and Rheumatism, Aug. 1987, 30(8): 914-918.
Garnero, et al.; “Bone Marrow Abnormalities on Magnetic Resonance Imaging Are Associated with Type II Collagen Degradation in Knee Osteoarthritis: A Three-Month Longitudinal Study”; Arthritis & Rheumatism, Sep. 2005, 52 (9): 2822-2829.
Guymer, et al.; “A Study of the Prevalence and Associations of Subchondral Bone Marrow Lesions in the Knees of Healthy, Middle-Aged Women”; Osteoarthritis and Cartilage, Dec. 2007, 15(12): 1437-1442.
Hunter, et al.; “Bone marrow lesions from osteoarthritis knees are characterized by sclerotic bone that is less well mineralized”, Arthritis Research & Therapy; Jan. 2009, 11(1): http://arthritis-research.com/content/11/1/R11.
Hunter, et al.; “Increase in Bone Marrow Lesions Associated with Cartilage Loss: A Longitudinal Magnetic Resonance Imaging Study of Knee Osteoarthritis”; Arthritis & Rheumatism, May 2006, 54(5): 1529-1535.
Jones, et al.; “Early Radiographic Osteoarthritis is Associated with Substantial Changes in Cartilage Volume and Tibial Bone Surface Area in Both Males and Females”; Osteoarthritis and Cartilage, Feb. 2004, 12(2): 169-174.
Mayerhoefer, et al.; “Short-term outcome of painful bone marrow oedema of the knee following oral treatment with iloprost or tramadol: results of an exploratory phase II study of 41 patients”; Rheumatology 2007, Jul. 2007: 1-6.
McQueen, F.M.; “A vital clue to deciphering bone pathology: MRI bone oedema in rheumatoid arthritis and osteoarthritis”; Annals of the Rheumatic Diseases 2007, 66: 1549-1552.
Radin, et al.; “Role of Subchondral Bone in the Initiation and Progression of Cartilage Damage”; Clinical Orthopaedics and Related Research, Dec. 1986, 213: 34-40.
Segal, et al.; “Baseline Articular Contact Stress Levels Predict Incident Symptomatic Knee Osteoarthritis
Leinberry Charles F.
Sharkey Peter F.
Blanco Javier
Knee Creations, LLC
Monument IP Law Group
Willse David H
LandOfFree
Osteoarthritis treatment and device does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Osteoarthritis treatment and device, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Osteoarthritis treatment and device will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4262755